Lisa Hopcroft
Data Scientist
Lisa Hopcroft is a Data Scientist previously working for the Bennett Institute on OpenSAFELY. Following a BSc in AI and Psychology, Lisa’s postgraduate studies (MRes, PhD) focussed on applied computing in biomedical research. Her post-doctoral work sought to elucidate insight from high-dimensional and complex transcriptomic data in leukaemia. Before joining the OpenSAFELY team at The Data Lab, Lisa was a Principal Information Analyst at Public Health Scotland, working on phase I-III clinical trials and on the COVID-19 in Pregnancy in Scotland (COPS) project.
Papers by Lisa Hopcroft
- The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate
- Measuring BMI in 22 million patients in England
- Consistency, completeness and external validity of ethnicity recording in NHS primary care records
- Impact of COVID-19 on recorded blood pressure screening and hypertension management in England
- Eleven key measures for monitoring general practice clinical activity during COVID-19
- Data-driven identification of potentially successful intervention implementations: a proof of concept using five years of opioid prescribing data from over 7000 practices in England
- Changes in medication safety indicators in England throughout the covid-19 pandemic using OpenSAFELY
- Data-Driven Identification of Unusual Prescribing Behavior: Analysis and Use of an Interactive Data Tool Using 6 Months of Primary Care Data From 6500 Practices in England
- First dose COVID-19 vaccine coverage amongst adolescents and children in England
- Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings
- Identifying Patterns of Clinical Interest in Clinicians' Treatment Preferences: Hypothesis-free Data Science Approach to Prioritizing Prescribing Outliers for Clinical Review
- Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose
- Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England
- Effectiveness of BNT162b2 booster doses in England
Blog posts by Lisa Hopcroft
- An Update on Our Co-piloting Programme: How Have We Grown?
- An Update on Our Co-piloting Programme: What's New?
- Identifying over prescribed chemicals: a data-driven approach to mining prescription data
- Identifying outlier prescribing behaviour: how is your practice unusual?
- First Impressions of a New Start